Midori Isobe

1.1k total citations
27 papers, 660 citations indexed

About

Midori Isobe is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Midori Isobe has authored 27 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 15 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Midori Isobe's work include Immunotherapy and Immune Responses (15 papers), T-cell and B-cell Immunology (9 papers) and vaccines and immunoinformatics approaches (7 papers). Midori Isobe is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), T-cell and B-cell Immunology (9 papers) and vaccines and immunoinformatics approaches (7 papers). Midori Isobe collaborates with scholars based in Japan, United States and Australia. Midori Isobe's co-authors include Eiichi Nakayama, Mikio Oka, Yoshihiro Ohue, Akiko Uenaka, Koji Kurose, Hisashi Wada, Kazuhiro Kakimi, Heiichiro Udono, Lloyd J. Old and Shingo Eikawa and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Midori Isobe

25 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Midori Isobe Japan 13 501 337 179 63 38 27 660
Jennifer S. Childs United States 14 581 1.2× 529 1.6× 232 1.3× 160 2.5× 47 1.2× 46 812
Biwei Zhao United States 9 437 0.9× 223 0.7× 272 1.5× 38 0.6× 17 0.4× 13 608
Pamela Beatty United States 12 319 0.6× 224 0.7× 197 1.1× 50 0.8× 26 0.7× 21 509
Iñigo Tirapu Spain 17 559 1.1× 457 1.4× 213 1.2× 44 0.7× 20 0.5× 32 888
Jaina M. Patel United States 12 237 0.5× 161 0.5× 158 0.9× 27 0.4× 57 1.5× 18 408
Brian J. Czerniecki United States 12 413 0.8× 342 1.0× 180 1.0× 68 1.1× 25 0.7× 23 615
Amelia J. Tesone United States 9 473 0.9× 406 1.2× 362 2.0× 17 0.3× 58 1.5× 12 860
Atsunori Hiasa Japan 10 459 0.9× 280 0.8× 214 1.2× 127 2.0× 18 0.5× 16 701
Olga Blomberg Netherlands 9 303 0.6× 293 0.9× 181 1.0× 140 2.2× 42 1.1× 9 583
Patrícia Cruz Bergami-Santos Brazil 10 409 0.8× 217 0.6× 169 0.9× 11 0.2× 36 0.9× 20 576

Countries citing papers authored by Midori Isobe

Since Specialization
Citations

This map shows the geographic impact of Midori Isobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Midori Isobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Midori Isobe more than expected).

Fields of papers citing papers by Midori Isobe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Midori Isobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Midori Isobe. The network helps show where Midori Isobe may publish in the future.

Co-authorship network of co-authors of Midori Isobe

This figure shows the co-authorship network connecting the top 25 collaborators of Midori Isobe. A scholar is included among the top collaborators of Midori Isobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Midori Isobe. Midori Isobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohue, Yoshihiro, Koji Kurose, Takahiro Karasaki, et al.. (2019). Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti–Programmed Cell Death-1 Therapy in NSCLC. Journal of Thoracic Oncology. 14(12). 2071–2083. 34 indexed citations
2.
Ohue, Yoshihiro, Koji Kurose, Midori Isobe, et al.. (2016). Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells. Cancer Immunology Research. 4(12). 1049–1060. 40 indexed citations
3.
Ohue, Yoshihiro, et al.. (2016). Abstract A101: Role of TIM-3/Galectin-9 pathway in lung cancer. Cancer Immunology Research. 4(11_Supplement). A101–A101. 2 indexed citations
4.
Kurose, Koji, Yoshihiro Ohue, Hisashi Wada, et al.. (2015). Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients. Clinical Cancer Research. 21(19). 4327–4336. 179 indexed citations
5.
Eikawa, Shingo, Akihiro Hosoi, Hirokazu Matsushita, et al.. (2015). Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient. PLoS ONE. 10(8). e0136086–e0136086. 5 indexed citations
6.
Ohue, Yoshihiro, Koji Kurose, Hirofumi Matsumoto, et al.. (2014). Prolongation of Overall Survival in Advanced Lung Adenocarcinoma Patients with the XAGE1 (GAGED2a) Antibody. Clinical Cancer Research. 20(19). 5052–5063. 20 indexed citations
7.
Kurose, Koji, Yoshihiro Ohue, Eiichi Sato, et al.. (2014). Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760). Journal of Thoracic Oncology. 10(1). 74–83. 48 indexed citations
8.
Uenaka, Akiko, Midori Isobe, Hisashi Wada, et al.. (2014). Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patients. Vaccine. 32(8). 957–964. 2 indexed citations
9.
Wakamatsu, Kazumasa, Shosuke Ito, Akiko Uenaka, et al.. (2013). TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD). Journal of Dermatological Science. 73(3). 209–215. 4 indexed citations
10.
Eikawa, Shingo, Kazuhiro Kakimi, Midori Isobe, et al.. (2012). Induction of CD8 T‐cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20‐mer NY‐ESO‐1f (NY‐ESO‐1 91‐110) peptide. International Journal of Cancer. 132(2). 345–354. 24 indexed citations
11.
Kakimi, Kazuhiro, Midori Isobe, Akiko Uenaka, et al.. (2011). A phase I study of vaccination with NY‐ESO‐1f peptide mixed with Picibanil OK‐432 and Montanide ISA‐51 in patients with cancers expressing the NY‐ESO‐1 antigen. International Journal of Cancer. 129(12). 2836–2846. 66 indexed citations
12.
Ohue, Yoshihiro, Shingo Eikawa, Midori Isobe, et al.. (2011). Spontaneous antibody, and CD4 and CD8 T‐cell responses against XAGE‐1b (GAGED2a) in non‐small cell lung cancer patients. International Journal of Cancer. 131(5). E649–58. 33 indexed citations
13.
Tanaka, Kei, Midori Isobe, Hisashi Wada, et al.. (2010). Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients. Vaccine. 28(32). 5338–5346. 7 indexed citations
14.
Isobe, Midori, Shingo Eikawa, Akiko Uenaka, et al.. (2009). Correlation of high and decreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient.. PubMed. 9. 8–8. 13 indexed citations
15.
Tsuji, Kazuhide, Akiko Uenaka, Hisashi Wada, et al.. (2008). Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient. Cancer Immunology Immunotherapy. 57(10). 1429–1437. 37 indexed citations
16.
Wada, Hisashi, Eiichi Sato, Akiko Uenaka, et al.. (2008). Analysis of peripheral and local anti‐tumor immune response in esophageal cancer patients after NY‐ESO‐1 protein vaccination. International Journal of Cancer. 123(10). 2362–2369. 31 indexed citations
17.
Kawabata, Ryohei, Hisashi Wada, Midori Isobe, et al.. (2007). Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients. International Journal of Cancer. 120(10). 2178–2184. 58 indexed citations
18.
Momose, Tomoyasu, Yoshio Okubo, Shiro Horie, et al.. (1999). Interferon-γ Increases CD62L Expression on Human Eosinophils. International Archives of Allergy and Immunology. 120(Suppl. 1). 30–33. 16 indexed citations
19.
Kishimoto, Takuji, et al.. (1991). Cadmium injury of cultured human vascular endothelial cells.. PubMed. 4(4). 329–34. 9 indexed citations
20.
Ijiri, Yoshio, et al.. (1990). The Pharmacokinetics of Pranoprofen in Humans. YAKUGAKU ZASSHI. 110(7). 509–515. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer S. Childs Breakdown of academic impact, for papers by Biwei Zhao Breakdown of academic impact, for papers by Pamela Beatty Breakdown of academic impact, for papers by Iñigo Tirapu Breakdown of academic impact, for papers by Jaina M. Patel Breakdown of academic impact, for papers by Brian J. Czerniecki Breakdown of academic impact, for papers by Amelia J. Tesone Breakdown of academic impact, for papers by Atsunori Hiasa Breakdown of academic impact, for papers by Olga Blomberg Breakdown of academic impact, for papers by Patrícia Cruz Bergami-Santos
Rankless by CCL
2026